Krystal Biotech Stock Probability of Future Stock Price Finishing Under 174.57
| KRYS Stock | USD 186.60 4.31 2.36% |
Krystal |
Krystal Biotech Target Price Odds to finish below 174.57
The tendency of Krystal Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 174.57 or more in 90 days |
| 186.60 | 90 days | 174.57 | about 17.05 |
Based on a normal probability distribution, the odds of Krystal Biotech to drop to $ 174.57 or more in 90 days from now is about 17.05 (This Krystal Biotech probability density function shows the probability of Krystal Stock to fall within a particular range of prices over 90 days) . Probability of Krystal Biotech price to stay between $ 174.57 and its current price of $186.6 at the end of the 90-day period is about 47.27 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.49 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Krystal Biotech will likely underperform. Additionally Krystal Biotech has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Krystal Biotech Price Density |
| Price |
Predictive Modules for Krystal Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Krystal Biotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Krystal Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Krystal Biotech Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Krystal Biotech is not an exception. The market had few large corrections towards the Krystal Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Krystal Biotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Krystal Biotech within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.28 | |
β | Beta against Dow Jones | 1.49 | |
σ | Overall volatility | 9.13 | |
Ir | Information ratio | -0.1 |
Krystal Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Krystal Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Krystal Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Krystal Biotech generated a negative expected return over the last 90 days | |
| Krystal Biotech currently holds about 425.56 M in cash with (88.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 16.58. | |
| Over 88.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Jennison Associates LLC Sells 110,333 Shares of Krystal Biotech, Inc. - MarketBeat |
Krystal Biotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Krystal Stock often depends not only on the future outlook of the current and potential Krystal Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Krystal Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 27.8 M | |
| Cash And Short Term Investments | 532.2 M |
Krystal Biotech Technical Analysis
Krystal Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. Krystal Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Krystal Biotech. In general, you should focus on analyzing Krystal Stock price patterns and their correlations with different microeconomic environments and drivers.
Krystal Biotech Predictive Forecast Models
Krystal Biotech's time-series forecasting models is one of many Krystal Biotech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Krystal Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Krystal Biotech
Checking the ongoing alerts about Krystal Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Krystal Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Krystal Biotech generated a negative expected return over the last 90 days | |
| Krystal Biotech currently holds about 425.56 M in cash with (88.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 16.58. | |
| Over 88.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Jennison Associates LLC Sells 110,333 Shares of Krystal Biotech, Inc. - MarketBeat |
Additional Tools for Krystal Stock Analysis
When running Krystal Biotech's price analysis, check to measure Krystal Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Krystal Biotech is operating at the current time. Most of Krystal Biotech's value examination focuses on studying past and present price action to predict the probability of Krystal Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Krystal Biotech's price. Additionally, you may evaluate how the addition of Krystal Biotech to your portfolios can decrease your overall portfolio volatility.